The efficacy of treatment of psoriasis with TNF-α inhibitors [53], IL-17 inhibitors [53], and IL-23 inhibitors [54,55] as biological agents that suppress the function of specific cytokines has been demonstrated. Here, IL17A is linked to psoriasis.